Table 1. Clinical characteristics at the time of non-invasive cardiovascular testing in the RRI-CKD cohort for 198 subjects with carotid intima-media thickness measurements.
| Mean ±SD or % (n) | |
|---|---|
| Demographic/anthropomorphic measures | |
| Age (years) | 61 (14) |
| Body mass index (kg/m2) | 29.0 (6.3) |
| Male gender | 53% (104) |
| Race | |
| White | 76% (151) |
| Black | 19% (37) |
| Other | 5% (10) |
| Etiology of CKD | |
| Diabetes | 26% (51) |
| Hypertension | 53% (104) |
| Polycystic kidney disease | 7% (14) |
| Interstitial renal disease | 10% (20) |
| Glomerulonephritis | 33% (65) |
| Other | 13% (25) |
| Coronary risk factors | |
| Diabetes | 30% (59) |
| Hypertension | 99% (196) |
| Current smoker | 9% (17) |
| Former smoker | 40% (80) |
| Dyslipidemia | 87% (172) |
| Clinical CVD | |
| Any clinical CVD | 42% (84) |
| Cerebrovascular disease | 11% (21) |
| Coronary artery disease | 27% (53) |
| Peripheral arterial disease | 15% (29) |
| Heart failure | 19% (37) |
| Medications | |
| Diuretic | 49% (97) |
| Renin-angiotensin-aldosterone system inhibitor | 75% (148) |
| Beta-adrenergic receptor blocker | 51% (100) |
| Calcium channel blocker | 40% (79) |
| Erythropoiesis-stimulating agent | 23% (45) |
| Statin | 48% (94) |
| Aspirin | 39% (77) |
SD = standard deviation.